Anti-influenza Drugs Market, Global Outlook and Forecast 2022-2028

February 2022 | 61 pages | ID: A092042122A6EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Anti-influenza Drugs in Global, including the following market information:

Global Anti-influenza Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Anti-influenza Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oseltamivir Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anti-influenza Drugs include Roche, HEC Pharm, Shanghai Zhongxisanwei, GlaxoSmithKline, Guangzhou Pharmaceutical and Hunan Nucien Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-influenza Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-influenza Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Anti-influenza Drugs Market Segment Percentages, by Type, 2021 (%)

• Oseltamivir
• Zanamivir
• Peramivir
• Other

Global Anti-influenza Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Anti-influenza Drugs Market Segment Percentages, by Application, 2021 (%)

• Children
• Adults
• Elderly

Global Anti-influenza Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Anti-influenza Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti-influenza Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Anti-influenza Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• HEC Pharm
• Shanghai Zhongxisanwei
• GlaxoSmithKline
• Guangzhou Pharmaceutical
• Hunan Nucien Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti-influenza Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti-influenza Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI-INFLUENZA DRUGS OVERALL MARKET SIZE

2.1 Global Anti-influenza Drugs Market Size: 2021 VS 2028
2.2 Global Anti-influenza Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Anti-influenza Drugs Players in Global Market
3.2 Top Global Anti-influenza Drugs Companies Ranked by Revenue
3.3 Global Anti-influenza Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anti-influenza Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anti-influenza Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-influenza Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Anti-influenza Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Anti-influenza Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Anti-influenza Drugs Market Size Markets, 2021 & 2028
  4.1.2 Oseltamivir
  4.1.3 Zanamivir
  4.1.4 Peramivir
  4.1.5 Other
4.2 By Type - Global Anti-influenza Drugs Revenue & Forecasts
  4.2.1 By Type - Global Anti-influenza Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Anti-influenza Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Anti-influenza Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti-influenza Drugs Market Size, 2021 & 2028
  5.1.2 Children
  5.1.3 Adults
  5.1.4 Elderly
5.2 By Application - Global Anti-influenza Drugs Revenue & Forecasts
  5.2.1 By Application - Global Anti-influenza Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Anti-influenza Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Anti-influenza Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anti-influenza Drugs Market Size, 2021 & 2028
6.2 By Region - Global Anti-influenza Drugs Revenue & Forecasts
  6.2.1 By Region - Global Anti-influenza Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Anti-influenza Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Anti-influenza Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Anti-influenza Drugs Revenue, 2017-2028
  6.3.2 US Anti-influenza Drugs Market Size, 2017-2028
  6.3.3 Canada Anti-influenza Drugs Market Size, 2017-2028
  6.3.4 Mexico Anti-influenza Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Anti-influenza Drugs Revenue, 2017-2028
  6.4.2 Germany Anti-influenza Drugs Market Size, 2017-2028
  6.4.3 France Anti-influenza Drugs Market Size, 2017-2028
  6.4.4 U.K. Anti-influenza Drugs Market Size, 2017-2028
  6.4.5 Italy Anti-influenza Drugs Market Size, 2017-2028
  6.4.6 Russia Anti-influenza Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Anti-influenza Drugs Market Size, 2017-2028
  6.4.8 Benelux Anti-influenza Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Anti-influenza Drugs Revenue, 2017-2028
  6.5.2 China Anti-influenza Drugs Market Size, 2017-2028
  6.5.3 Japan Anti-influenza Drugs Market Size, 2017-2028
  6.5.4 South Korea Anti-influenza Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Anti-influenza Drugs Market Size, 2017-2028
  6.5.6 India Anti-influenza Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Anti-influenza Drugs Revenue, 2017-2028
  6.6.2 Brazil Anti-influenza Drugs Market Size, 2017-2028
  6.6.3 Argentina Anti-influenza Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Anti-influenza Drugs Revenue, 2017-2028
  6.7.2 Turkey Anti-influenza Drugs Market Size, 2017-2028
  6.7.3 Israel Anti-influenza Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Anti-influenza Drugs Market Size, 2017-2028
  6.7.5 UAE Anti-influenza Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Anti-influenza Drugs Major Product Offerings
  7.1.4 Roche Anti-influenza Drugs Revenue in Global Market (2017-2022)
  7.1.5 Roche Key News
7.2 HEC Pharm
  7.2.1 HEC Pharm Corporate Summary
  7.2.2 HEC Pharm Business Overview
  7.2.3 HEC Pharm Anti-influenza Drugs Major Product Offerings
  7.2.4 HEC Pharm Anti-influenza Drugs Revenue in Global Market (2017-2022)
  7.2.5 HEC Pharm Key News
7.3 Shanghai Zhongxisanwei
  7.3.1 Shanghai Zhongxisanwei Corporate Summary
  7.3.2 Shanghai Zhongxisanwei Business Overview
  7.3.3 Shanghai Zhongxisanwei Anti-influenza Drugs Major Product Offerings
  7.3.4 Shanghai Zhongxisanwei Anti-influenza Drugs Revenue in Global Market (2017-2022)
  7.3.5 Shanghai Zhongxisanwei Key News
7.4 GlaxoSmithKline
  7.4.1 GlaxoSmithKline Corporate Summary
  7.4.2 GlaxoSmithKline Business Overview
  7.4.3 GlaxoSmithKline Anti-influenza Drugs Major Product Offerings
  7.4.4 GlaxoSmithKline Anti-influenza Drugs Revenue in Global Market (2017-2022)
  7.4.5 GlaxoSmithKline Key News
7.5 Guangzhou Pharmaceutical
  7.5.1 Guangzhou Pharmaceutical Corporate Summary
  7.5.2 Guangzhou Pharmaceutical Business Overview
  7.5.3 Guangzhou Pharmaceutical Anti-influenza Drugs Major Product Offerings
  7.5.4 Guangzhou Pharmaceutical Anti-influenza Drugs Revenue in Global Market (2017-2022)
  7.5.5 Guangzhou Pharmaceutical Key News
7.6 Hunan Nucien Pharmaceutical
  7.6.1 Hunan Nucien Pharmaceutical Corporate Summary
  7.6.2 Hunan Nucien Pharmaceutical Business Overview
  7.6.3 Hunan Nucien Pharmaceutical Anti-influenza Drugs Major Product Offerings
  7.6.4 Hunan Nucien Pharmaceutical Anti-influenza Drugs Revenue in Global Market (2017-2022)
  7.6.5 Hunan Nucien Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Anti-influenza Drugs Market Opportunities & Trends in Global Market
Table 2. Anti-influenza Drugs Market Drivers in Global Market
Table 3. Anti-influenza Drugs Market Restraints in Global Market
Table 4. Key Players of Anti-influenza Drugs in Global Market
Table 5. Top Anti-influenza Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anti-influenza Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anti-influenza Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anti-influenza Drugs Product Type
Table 9. List of Global Tier 1 Anti-influenza Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-influenza Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anti-influenza Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anti-influenza Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anti-influenza Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Anti-influenza Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anti-influenza Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anti-influenza Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Anti-influenza Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anti-influenza Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anti-influenza Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anti-influenza Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anti-influenza Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anti-influenza Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anti-influenza Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anti-influenza Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anti-influenza Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anti-influenza Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anti-influenza Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anti-influenza Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anti-influenza Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Anti-influenza Drugs Product Offerings
Table 32. Roche Anti-influenza Drugs Revenue (US$, Mn), (2017-2022)
Table 33. HEC Pharm Corporate Summary
Table 34. HEC Pharm Anti-influenza Drugs Product Offerings
Table 35. HEC Pharm Anti-influenza Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Shanghai Zhongxisanwei Corporate Summary
Table 37. Shanghai Zhongxisanwei Anti-influenza Drugs Product Offerings
Table 38. Shanghai Zhongxisanwei Anti-influenza Drugs Revenue (US$, Mn), (2017-2022)
Table 39. GlaxoSmithKline Corporate Summary
Table 40. GlaxoSmithKline Anti-influenza Drugs Product Offerings
Table 41. GlaxoSmithKline Anti-influenza Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Guangzhou Pharmaceutical Corporate Summary
Table 43. Guangzhou Pharmaceutical Anti-influenza Drugs Product Offerings
Table 44. Guangzhou Pharmaceutical Anti-influenza Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Hunan Nucien Pharmaceutical Corporate Summary
Table 46. Hunan Nucien Pharmaceutical Anti-influenza Drugs Product Offerings
Table 47. Hunan Nucien Pharmaceutical Anti-influenza Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Anti-influenza Drugs Segment by Type in 2021
Figure 2. Anti-influenza Drugs Segment by Application in 2021
Figure 3. Global Anti-influenza Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti-influenza Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-influenza Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-influenza Drugs Revenue in 2021
Figure 8. By Type - Global Anti-influenza Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anti-influenza Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anti-influenza Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anti-influenza Drugs Revenue Market Share, 2017-2028
Figure 12. US Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anti-influenza Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anti-influenza Drugs Revenue Market Share, 2017-2028
Figure 24. China Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anti-influenza Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anti-influenza Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anti-influenza Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Anti-influenza Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. HEC Pharm Anti-influenza Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Shanghai Zhongxisanwei Anti-influenza Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GlaxoSmithKline Anti-influenza Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Guangzhou Pharmaceutical Anti-influenza Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Hunan Nucien Pharmaceutical Anti-influenza Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)